Litcius/Paper detail

Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer

Claudette Falato, Francesco Schettini, Tomás Pascual, Fara Brasó‐Maristany, Aleix Prat

2022Cancer Treatment Reviews65 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHER2 negativeHormone receptorMetastatic breast cancerBreast cancerOncologyInternal medicineReceptorCancerCancer researchAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer Research
Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer | Litcius